Vita Antonio, Barlati Stefano, Cavallaro Roberto, Mucci Armida, Riva Marco A, Rocca Paola, Rossi Alessandro, Galderisi Silvana
Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
Department of Mental Health and Addiction Services, Azienda Socio-Sanitaria Territoriale (ASST) Spedali Civili of, Brescia, Italy.
Front Psychiatry. 2024 Sep 20;15:1451832. doi: 10.3389/fpsyt.2024.1451832. eCollection 2024.
A considerable proportion of patients with schizophrenia perform below population norms on standardized neuropsychological tests, and the performance of those performing within normal range is lower than predicted based on parental education. Cognitive impairment predates the onset of psychosis, is observed during symptom remission and in non-affected first-degree relatives of patients. At the present time, cognitive deficits are regarded as key features of schizophrenia, important determinants of poor psychosocial outcome and targets for both pharmacological and non-pharmacological treatment strategies. A group of eight key opinion leaders reviewed and discussed latest advances in scientific research and current good clinical practices on assessment, management, and treatment of CIAS. In the present paper they summarize the current evidence, identify main gaps between current knowledge and mental health services clinical practice, and provide practical recommendations to reduce the gap.
相当一部分精神分裂症患者在标准化神经心理学测试中的表现低于总体人群标准,而那些表现处于正常范围内的患者的表现也低于基于父母教育程度所预测的水平。认知障碍在精神病发作之前就已出现,在症状缓解期以及患者未受影响的一级亲属中也可观察到。目前,认知缺陷被视为精神分裂症的关键特征、心理社会预后不良的重要决定因素以及药物和非药物治疗策略的靶点。一组八位关键意见领袖回顾并讨论了关于精神分裂症认知障碍评估、管理和治疗的科学研究最新进展以及当前良好临床实践。在本文中,他们总结了当前证据,确定了当前知识与心理健康服务临床实践之间的主要差距,并提供了缩小差距的实用建议。